...
首页> 外文期刊>Cardiovascular drugs and therapy >A New Class III Antiarrhythmic Drug Niferidil Prolongs Action Potentials in Guinea Pig Atrial Myocardium via Inhibition of Rapid Delayed Rectifier
【24h】

A New Class III Antiarrhythmic Drug Niferidil Prolongs Action Potentials in Guinea Pig Atrial Myocardium via Inhibition of Rapid Delayed Rectifier

机译:一种新的III类抗心律失常药物Niferidil通过抑制快速延迟整流器延长了豚鼠心房心肌的作用潜力

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Purpose A new class III antiarrhythmic drug niferidil (RG-2) has been introduced as a highly effective therapy for cases of persistent atrial fibrillation, but ionic mechanisms of its action are poorly understood. In the present study, the effects of niferidil on action potential (AP) waveform and potassium currents responsible for AP repolarization were investigated in guinea pig atrial myocardium. Methods APs were recorded with sharp glass microelectrodes in multicellular atrial preparations. Whole-cell patch-clamp technique was used to measure K + currents in isolated myocytes. Results In multicellular atrial preparations, 10 ?8 ?M niferidil effectively prolonged APs by 15.2?±?2.8% at 90% repolarization level. However, even the highest tested concentrations, 10 ?6 ?M and 10 ?5 ?M failed to prolong APs more than 32.5% of control duration. The estimated concentration of niferedil for half-maximal AP prolongation was 1.13?×?10 ?8 ?M. Among the potassium currents responsible for AP repolarization phase, I K1 was found to be almost insensitive to niferidil. However, another inward rectifier, I KACh , was effectively suppressed by micromolar concentrations of niferidil with IC 50 ?=?9.2?×?10 ?6 ?M. I KATP was much less sensitive to the drug with IC 50 ?=?2.26?×?10 ?4 ?M. The slow component of delayed rectifier, I Ks , also demonstrated low sensitivity to niferidil—the highest used concentration, 10 ?4 ?M, decreased peak I Ks density to 46.2?±?5.5% of control. Unlike I Ks , the rapid component of delayed rectifier, I Kr , appeared to be extremely sensitive to niferidil. The IC 50 was 1.26?×?10 ?9 ?M. I Kr measured in ventricular myocytes was found to be less sensitive to niferidil with IC 50 ?=?3.82?×?10 ?8 ?M. Conclusions Niferidil prolongs APs in guinea pig atrial myocardium via inhibition of I Kr .
机译:摘要目的是一种新的III类抗真瘤药物Niferidil(RG-2)被引入了持续的心房颤动病例的高效治疗,但其行为的离子机制尚不清楚。在本研究中,在豚鼠心房心脏中研究了NiFeridil对AP再渗变的动作电位(AP)波形和钾电流的影响。方法用多细胞室间制剂中的夏普玻璃微电极记录APS。全细胞贴片技术用于测量分离的肌细胞中的K +电流。导致多细胞心房制剂,10?8?M Niferidil有效地延长了15.2°αα±2.8%的再渗透水平。然而,即使是最高的测试浓度,10?6?m和10?5?m未能延长32.5%的控制持续时间。半最大AP延长的Niferedil的估计浓度为1.13?×10?8?m。在负责AP复极化阶段的钾电流中,发现I K1几乎对NiFeridil几乎不敏感。然而,通过IC 50的微摩尔浓度有效地抑制了另一种向内的整流器,I kACH是有效抑制的NiForar浓度?=Δ9.2?×10?6?米。我用IC 50对药物敏感的敏感性要不那么敏感?=?2.26?×10?4?米。延迟整流器,I ks的缓慢分量也表现出对Niferidil的敏感性 - 最高使用的浓度,10?4?m,峰值I ks密度降低至46.2?±5.5%的控制。与I KS不同,延迟整流器I KR的快速成分似乎对NiFeridil非常敏感。 IC 50为1.26?×10?9?m。发现在心室肌细胞中测量的kr对尼草胺与IC 50的敏感性较小?=Δ3.82?×10?8?m。结论Niferidil通过I KR抑制抑制豚鼠心房心肌的AP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号